Summary; Despite a strong cytotoxic T-lymphocyte (CTL) response directed against viral antigens, untreated individuals infected with the human immunocieficiency virus (HIV-]) develop AIDS, We have found that primary T cells infected with HIV-1 downregulate surface MHC cUbs I antigens and are resistant to lysis by HLA-A2-restricted CTL clones. In contrast, cells infected with an HIV-1 in which the nef gene is disrupted are sensitive to CTLs in an MHC and peptide-specific manner. In primary T cells HLA-A2 antigens are downmodulated more dramatically than total MHC class I antigens, suggesting that nef selectively downmodiilates certain MHC class I antigens. In support of this, studies on ceils expressing individual MHC class I alietes have revealed that nef does not downmodulate HLA-C and HLA-E antigens, Tliis selective downmoduiation allows Infected cells to maintain resistance to certain natural killer cells ihu lyse infected cells expressing low levels of MHC class I antigens. Downmoduiation of MHC class I HLA-A2 antigens occurs not only in primary T cells, but also in B and astrocytoma cell hnes. No effect of other HIV-1 accessory proteins such as vpu and vpr was observed. Thus Nef is a protein that may promote escape of HIV-1 from immune surveillance.
Introduction
A dramatic increase in onr knowledge of the natnral history of human immttnodeficiency virus (HIV) infection has yielded insights into mechanisms of HIV disease pathogenesis. After exposure to HIV an infected individual becomes acutely viremic. This phase subsequently resolves coincident with the appearance of anti-HIV cytotoxic T lymphocytes (CTLs) (1, 2) . Thereafter infected individuals experience a period of clinical latency that is variable in length and proportional to the amount of circulating virus (3). It is not until much later, when HIV has destroyed most of the host's CD4+ T cells, that the infected individual becomes symptomatic with opportunistic infections that the weakened immune system can no longer contain. Coincident with the drop in CD4+ T cells and the appearance of opportimistic infections, there is also a rise in HIV loads presumably because the immune system completely fails to contain HIV (4) (5) (6) .
A shortened half life of infected CD4+ T cells has been demonstrated both in vivo and in vitro and is due at least in part [ Cytotoxic T Lymphocyte to the direct toxic effects of HIV (7) (8) (9) (10) (11) (12) (13) (14) . Additional destruction may be mediated by the host's immune response against infected cells. Thus a disease model has evolved in which viral loads are maintained by successive rounds of newly infected CD4' *' T cells that live just long enough to produce the next round of viral progeny The precise contribution of sequestered reservoirs and longer lived celts such as infected macrophages has not yet been well worked out (for review see (15)),
In an infected individual multiple factors determine viral levels including the effectiveness of the host's immune response and the genetics of the particular infecting viral strain. In support of the importance of host factors, studies using MHC class I HLA-tetrameric complexes to identify anti-HIV CTLs have indicated an inverse correlation between the quantity of anti-HIV CTLs and viral load (16). In addition, a role for CTLs in controlling HIV-l infection in vivo is supported by individual patient studies in which variant HIV epitopes appear to have been selected by a strong immune response (17-19). These studies suggest an important role for CTLs in the control of virus load.
CTLs detect infected cells through the T-cell receptor and CD8 molecules which recognize foreign peptides assembled in the groove of MHC class I proteins and expressed on the surface of almost all mammalian cells (Fig, 1) . The peptides are derived from cytosohc proteins which are digested by the proteasome and transported into the endoplasmic reticulum where they assemble with the MHC class I heavy and light chains (Fig. 2) , In addition to this classical mode of CTL activation, CTLs can also become activated by other routes: for instance, phagocytes and dendritic cells can ingest antigens and present them in association with MHC class I antigens (20-22).
CTLs are well known for their ability to lyse cells expressing foreign antigens by the release of granzymes and perforins and by tbe activation of Fas-mediated killing (23) . However they may have more than one defense mechanism against HIV In addition to the traditional cytolytic responses, activated anti-HIV CTLs secrete soluble substances including chemokines that potently inhibit infection by HIV (24) (25) (26) The critical role of viral determinants in the establishment of high viral loads is best illustrated by the requirement of an intact nef gene for the development of AIDS in humans and monkeys (27) (28) (29) . Nef is a 27-34 kDa myristoylated protein that has several conserved domains which appear to be important for its function (Fig. 3) . Notably, there is a conserved acidic domain of unclear function and several proline-rich domains.
The first proline-rich domain has been shown to be important We then demonstrated that the ability of CTLs to recognize infected cells could be restored by preincubating infected cells with synthetic peptide epitope (33). We were thus able to demonstrate that HIV-infected cells escape CTL recognition by reducing the density of antigenic peptide complexed to MHC class I antigen on the celi surface. A partial reduction in surface MHC class I antigen with HIV-1 infection has been reported previously (25, 34, 35) , and has been attributed variably to nef, vpu and tot (36) (37) (38) . Nef is required for MHC class I downmodulafion whereas vpu and vpr are not. Priiiury CD4* T LCUS were infected with NL-PI coniaiiiiiim utacions in Def, vpu or vpr genes. Infected ceils were then stained with antibodies against HLA-A2 antigens and against PLAP, A nnll mutation was introduced in vpu hy using a PCR-ha.sed approach to change the ATG tf) ACG, A frameshift mutation was introduced into vpr by filling in the Afl II site in the vpr open reading frame. The mutant containing both vpu and vpr mutations was constructed by substituting the Sai I-Spe I fragment of NLPIgag'H-pu" with the Sal I-Spe I fragment of NLPIgag'^vpr , All nef mutations were made by ablating the N-termina! unique Xho I site (32, 33) , The absence of the mutant protein was confirmed for each by western blot.
-Log PLAP fluorescence results). It is important to point out, however, that some NK cells may require MHC class I HLA-B antigens for inhibition (46) , that there are anti-HIV-HLA-C-res trie ted CTL (47) (48) (49) and that HLA-E can on some occasions activate NK cells (50) , All of our experiments were performed with cells infected with a lab-adapted virus that expresses PLAP (Fig. 4) . It will thus be important to demonstrate that our results are generahzable to cells infected with naturally occurring viruses or so-called "primary isolates". As a first step towards this goal we asked whether we could detect MHC class I antigen downmodulation by staining cells for intracellular Gag rather than with PLAP. Surprisingly we found that it was much more difficult to detect the effects of nef using an intracellular stain. It is probably the fixation process required for intracellular staining that makes the experiment so unconvincing (Fig, 5C) To explore the role of vpu and vpr in MHC class I downmodulation and protection of infected cells from CTLs, we inserted PLAP into a HIV-l molecular clone, NL-PI, which expresses these genes (and contains many other variations in sequence (33) ). In NL-PI there are two amino acid changes within the relevant gag epitope which result in non-recognition by the anti-gag CTL clones described above (S, Kalams, manuscript in preparation). Therefore, to create a version that could be recognized by the CTL clones, the N-terminus of HXB-PI gag was inserted into NL-PI (NL-PIgag™ (33)).
The results we obtained with NL-PIgag"™ were very similar to what we observed with HXB-PI. Cells infected with NL-PI depended on nef for MHC class I downregulation; there was no more than twofold residual downregulation in the absence of a functional nef gene. A CTL killing assay suggested tbat there might be another protective factor in NL-PI because nef NL-PI constructs survived better than nef-HXB constructs (40% versus 10% (33) and/or vpr. In contrast with the dramatic effect of nef, we observed no significant effect of vptj and vpr expression on MHC class I downmodulation (Fig. 6) . Additionally, we were unable to detect any effect of vpu and/or vpr expression on the ability of CTLs to recognize and lyse infected primary T cells that did not express nef (Fig. 7) . Most of our work is based on HLA-A2-restricted CTLs recognizing a Gag epitope and we cannot rule out an effect of these genes on other MHC class I antigens and on the ability of CTLs to recognize other viral antigens.
Timing of MHC class I antigen downmodulation
All of our CTL assays were performed by mixing CTLs with target cells that had already been infected for at least 48 h. This system differs from the in vivo situation where CTLs are continuously exposed to virally infected cells at all stages of infection.
To determine whether there might be a window of time before MHC class 1 downmodulation occurs when CTLs could recognize infected cells, we performed a time course in wbich cells were sarnpled and stained at varying times after infection. We found that at 24 h, we could just begin to see PLAP staining and downmodulation of MHC class I antigens (Fig. 8.4) , By 48 h we could detect brightly staining PLAP-positive cells and complete downmodulation of MHC class I antigens (Fig. 8B) . We have . We found that HIV expressing nef dramatically downmodulated MHC class I HLA-A2 antigens on both cell lines in a nef-dependent manner. Interestingly, both cell lines express higher levels of HLA-A2 antigens than primary T cells, and nef leaves a correspondingly higher residual amount of MHC class I antigens on these cells. It will be important to determine whether related cell types such as primary macrophages important for infection in vivo similarly have high residual MHC class I antigens. If true, these cells may be more susceptible to CTLs than the primary CD4"^ T cells we have tested thus far. Interestingly, macrophages have recently been shown to be important for high viral loads in end stage individuals with low CD4 cotmts (and presumably poor GTL function) (51).
Closing remarks
The development of the HIV PLAP system has provided us with a unique probe to better understand HIV-induced disease pathogenesis. Using this approach various groups in the Baltimore laboratory have demonstrated the independent contributions of nef, vpu and env genes in the downmoduiation of GD4 (32) , the role of nef in protecting primary T cells from CTLs The mechanism of Nef-mediated MHC class I dow^nmodu-lation is currently being explored by a number of groups and is gradually coming to light. Interestingly, it appears that different domains of nef are required for MHC class I dowTimodulation versus nef-mediated CD4 downmoduiation. Recent data has implicated the acidic and proline-rich regions of nef as being important for MHC class I downmoduiation (41), whereas we have not found the proline-rich region to be important for CD4 downmoduiation (30) . Additional evidence supporting a separate mechanism for MHG class I antigen downmoduiation is that expression of nef leads to localization of CD4 molecules to membrane-associated clathrin-coated pits (52), whereas Nef directs MHC class I antigens to the trans-Golgi (40, 41) . How a single 27 kDa protein mediates the downmoduiation of two very different cell surface molecules by two different mechanisms will be very interesting to learn. Nef has been reported to interact with a host of cellular factors and it is possible that nef' s differential association with these factors is important for its multiple activities. Three different cellular factors have nowbeen imphcated in GD4 downmoduiation based on mutagenesis studies: a thioesterase (53) (G. B. Cohen, D. Baltimore, unpublished results), the u subunit of a clathrin adaptor (40, 54) and a vacuolar ATPase (55) . However, none have yet been directly implicated in MHG class I downmoduiation. A greater understanding of the relevant cellular partners will belp speed the development of effective anti-nef pharmaceuticals. Hopefully these would help control virus infection by allowing the host's immune system to be more effective.
Our studies demonstrate that nef-mediated MHG class I dowai modulation can be profound and that nef-exprcssing cells with low levels of MHC class I antigens have a survival advantage in the presence of CTLs. Based on these findings we expect that Nef-expressing cells will survive longer in vivo, produce more infectious viral particles, and expose the immune system to a greater diversity of antigenic variants. Thus the activity of nef is likely to be synergistic with other reported mechanisms of HIV escape from GTLs that rely on antigenic variation.
A growing number of studies suggest that antigenic variation is an important element of HIV immune evasion. Individual patients with immunodominant GTL responses can escape the GTL response by generating antigenic variants not recognized by CTLs (17-19). In addition, some individuals who mount a CTL response to the immunodominant strain appear to lack the ability to respond to immunogenic variants that arise later (56) (57) (58) . Furthermore, it has been reported that certain types of peptides that are sequence variants of the cognate peptide antigens recognized by antigen-specific T-cell receptors can act as antagonists (59, 60) .
The effects of nef are likely to be aided by other mechanisms that diminish the anti-HIV CTL response. Macrophages (and possibly T cells) can directly kill some anti-HIV CTLs (61, 62) . In addition, preferential depletion of anti-HIV GD4+ T cells probably leads to anti-HIV CTL anergy because of a lack of T-cell help (63, 64) . It is also probable that reservoirs of HIVinfected cells exist that are sequestered in sites where access to CTL is restricted, such as the brain. Finally truly latent cells with integrated provirus that does not express viral proteins are hkely to be resistant to CTL (for review see (15)). It is not surprising that HIV employs multiple mechanisms to evade the host's immune system given the almost universal lethality of virus infection in untreated individuals. Hopefully a greater understanding of precisely how the immune system is weakened will provide ways of designing more effective therapeutics and better vaccination strategies.
